Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy

BACKGROUND: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of colon cancer because it has been recurred and produced few side effects in patients. Secretory glycoprotein 90K has been found at elevated level in various cancer tissues and sera. We investigated to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hee, Park, Myung Suk, Chung, Ik Joo
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026940/
https://www.ncbi.nlm.nih.gov/pubmed/21286381
http://dx.doi.org/10.4110/in.2010.10.6.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026940/
https://www.ncbi.nlm.nih.gov/pubmed/21286381
http://dx.doi.org/10.4110/in.2010.10.6.206

Ejemplares similares